Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.14T
Market cap1.14T
Price-Earnings ratio
43.70
Price-Earnings ratio43.70
Dividend yield
0.53%
Dividend yield0.53%
Average volume
3.76M
Average volume3.76M
High today
$1,214.97
High today$1,214.97
Low today
$1,201.10
Low today$1,201.10
Open price
$1,195.80
Open price$1,195.80
Volume
14.70K
Volume14.70K
52 Week high
$1,238.00
52 Week high$1,238.00
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,207.00. The company's market cap stands at 1.14T, with a P/E ratio of 43.70 and a dividend yield of 0.53%.

During the trading session on 2026-07-06, Eli Lilly(LLY) shares reached a daily high of $1,214.97 and a low of $1,201.10. At a current price of $1,207.00, the stock is +0.5% higher than the low and still -0.7% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 14.7K, versus its average volume of 3.76M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.

The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.

LLY News

Investing.com 2h
Cantor Fitzgerald raises Eli Lilly stock price target on strong outlook - Investing.com

...

Cantor Fitzgerald raises Eli Lilly stock price target on strong outlook - Investing.com
TipRanks 2h
Eli Lilly price target raised to $1,350 from $1,230 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Eli Lilly (LLY) to $1,350 from $1,230 and keeps an Overweight rating on the shares. Large-cap biopharmas are...

Nasdaq 4h
Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)

Key Points Eli Lilly is the leader in the GLP-1 drug market. This leadership has supercharged earnings growth and stock performance in recent years. 10 stock...

Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

Nasdaq 7h
DKSH Signs Distribution And Promotion Agreement With Eli Lilly And Co In Hong Kong, Macau

(RTTNews) - DKSH Holding AG (DKSH.SW, DKSH), a Swiss market expansion services provider, on Monday has entered into a distribution and promotion agreement with...

DKSH Signs Distribution And Promotion Agreement With Eli Lilly And Co In Hong Kong, Macau
Simply Wall St 1d
Should Expanded Medicare GLP‑1 Access and New Oncology Wins Require Action From Eli Lilly Investors?

In late June 2026, Eli Lilly reported strong Q1 results, advanced its obesity and diabetes franchise with Medicare’s GLP‑1 Bridge program, and gained a positive...

Should Expanded Medicare GLP‑1 Access and New Oncology Wins Require Action From Eli Lilly Investors?
Nasdaq 2d
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Key Points Johnson & Johnson's CEO recently explained that his company isn't going to get caught up in the GLP-1 weight loss drug race. Instead, the company w...

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?
24/7 Wall St. 5d
Eli Lilly Price Prediction: The Case for Double-Digit Upside

Eli Lilly Price Prediction: The Case for Double-Digit Upside By Vandita Jadeja Published Jul 1, 1:18PM EDT Quick Read LLY earns a BUY rating with a $1,349 pri...

Eli Lilly Price Prediction: The Case for Double-Digit Upside
Benzinga 5d
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China

Innovent Biologics, Inc. and Eli Lilly and Co. (NYSE:LLY) on Tuesday entered into a distribution and promotion agreement for Eli Lilly’s breast cancer therapy V...

Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China
TipRanks 6d
Eli Lilly Stock Retreats as China Threats Emerge

Eli Lilly’s (LLY) stock is down about 2% on June 30 amid reports that generic versions of weight-loss drugs are emerging in China. Unlock powerful investing to...

Nasdaq 6d
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #8 broker pick, on average, out of the 30 stocks ma...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.